Search clinical trials for: Dose Level 3B: 2 x 10^8 cells/m2
Total 145 results
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingEBV-Related Hodgkin Lymphoma | EBV Related Non-Hodgkin's Lymphoma | EBV-Related Lymphoproliferative DisorderUnited States
-
Carina Biotech LimitedRecruitingColorectal Cancer MetastaticAustralia
-
University of OxfordCompleted
-
The First Affiliated Hospital of Soochow UniversityFundamenta Therapeutics, Ltd.RecruitingB Cell Lymphoma | CAR | Relapsed Non-Hodgkin LymphomaChina
-
GlaxoSmithKlineCureVacCompletedInfluenza, HumanBelgium, Spain, Canada
-
S.Biomedics Co., Ltd.Dt&SanomedicsActive, not recruitingCritical Limb IschemiaKorea, Republic of
-
AlloVirBaylor College of Medicine; The Methodist Hospital Research Institute; Center...Completed
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Autoimmunity Centers of ExcellenceTerminatedPemphigus Vulgaris | Pemphigus FoliaceusUnited States
-
PATHCompleted
-
Baylor College of MedicineUniversity of Texas, Southwestern Medical Center at DallasCompletedLeukemia | CancerUnited States
-
Emergent BioSolutionsCompleted
-
Medical College of WisconsinNot yet recruiting
-
Janssen Research & Development, LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Miltenyi Biomedicine GmbHICON plcActive, not recruitingB-cell Non Hodgkin LymphomaGermany
-
University of OxfordNational Institute for Health Research, United Kingdom; The PATH Malaria Vaccine...CompletedPlasmodium Falciparum MalariaUnited Kingdom
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbHCompleted
-
University of Michigan Rogel Cancer CenterRush University Medical CenterCompletedPancreatic CancerUnited States
-
Italian Sarcoma GroupFrench Sarcoma Group; Grupo Espanol de Investigacion en SarcomasActive, not recruitingLocalized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in AdultsSpain, Italy
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
The University of Hong KongLondon School of Hygiene and Tropical Medicine; Nagasaki UniversityEnrolling by invitation
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerChina
-
University of PittsburghGenentech, Inc.Completed
-
NovartisTerminatedHypertensionUnited States, Denmark, Finland, Norway, Sweden
-
Guangdong Raynovent Biotech Co., LtdCompletedCOVID-19 (Coronavirus Disease 2019)China
-
Hellenic Oncology Research GroupTerminated
-
PfizerCompleted
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRecruitingCord Blood Transplant | High Risk Myeloid MalignanciesUnited States
-
Medical University of ViennaPolymun Scientific, Vienna, AustriaCompleted
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
PfizerRecruitingHealthy ParticipantsUnited States
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's HospitalRecruitingAcute Myeloid LeukemiaChina
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Göteborg UniversityVastra Gotaland RegionCompleted
-
University Health Network, TorontoActive, not recruitingAxial SpondyloarthritisCanada
-
Spanish Clinical Pharmacology SocietySpanish reumatology SocietyCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)Not yet recruitingMetastatic Osteosarcoma | Localized Osteosarcoma | Unresectable Osteosarcoma | Resectable Osteosarcoma
-
University of NebraskaNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Hepatosplenic T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-Negative | Stage II Angioimmunoblastic T-cell Lymphoma | Stage II Enteropathy-Associated T-Cell Lymphoma | Stage III Angioimmunoblastic... and other conditionsUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid NeoplasmUnited States
-
Children's Oncology GroupNot yet recruitingStage I Kidney Wilms Tumor | Stage II Kidney Wilms Tumor | Stage III Kidney Wilms Tumor | Stage IV Kidney Wilms Tumor
-
Prescient Therapeutics, Ltd.National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Breast AdenocarcinomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre LaboratoriesActive, not recruitingPrimary Central Nervous System LymphomaFrance
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell Lymphoma | Double Expressor Lymphoma | High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 RearrangementsUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Stanford UniversityCompletedLymphoma | Hodgkin Disease | Lymphoma, Hodgkin Disease | Lymphoma: HodgkinUnited States